vs
Side-by-side financial comparison of ACME UNITED CORP (ACU) and MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI). Click either name above to swap in a different company.
ACME UNITED CORP is the larger business by last-quarter revenue ($52.3M vs $49.9M, roughly 1.0× MARAVAI LIFESCIENCES HOLDINGS, INC.). ACME UNITED CORP runs the higher net margin — 1.9% vs -71.6%, a 73.4% gap on every dollar of revenue. On growth, ACME UNITED CORP posted the faster year-over-year revenue change (13.8% vs -11.8%). Over the past eight quarters, ACME UNITED CORP's revenue compounded faster (-2.9% CAGR vs -11.9%).
Acme United Corporation is a supplier of cutting, measuring and safety products for the school, home, office, hardware and industrial markets. The company was organized as a partnership in 1867 and incorporated in 1873 under the laws of the State of Connecticut. It is publicly traded on the NYSE American with symbol ACU.
Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.
ACU vs MRVI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $52.3M | $49.9M |
| Net Profit | $985.0K | $-35.7M |
| Gross Margin | 39.7% | 25.8% |
| Operating Margin | 3.3% | -117.9% |
| Net Margin | 1.9% | -71.6% |
| Revenue YoY | 13.8% | -11.8% |
| Net Profit YoY | -40.4% | -37.7% |
| EPS (diluted) | $0.24 | $-0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $52.3M | — | ||
| Q4 25 | $47.5M | $49.9M | ||
| Q3 25 | $49.1M | $41.6M | ||
| Q2 25 | $54.0M | $47.4M | ||
| Q1 25 | $46.0M | $46.9M | ||
| Q4 24 | $45.9M | $56.6M | ||
| Q3 24 | $48.2M | $69.0M | ||
| Q2 24 | $55.4M | $69.4M |
| Q1 26 | $985.0K | — | ||
| Q4 25 | $1.9M | $-35.7M | ||
| Q3 25 | $1.9M | $-25.6M | ||
| Q2 25 | $4.8M | $-39.6M | ||
| Q1 25 | $1.7M | $-29.9M | ||
| Q4 24 | $1.7M | $-25.9M | ||
| Q3 24 | $2.2M | $-97.1M | ||
| Q2 24 | $4.5M | $-9.8M |
| Q1 26 | 39.7% | — | ||
| Q4 25 | 38.2% | 25.8% | ||
| Q3 25 | 39.1% | 13.6% | ||
| Q2 25 | 41.0% | 16.4% | ||
| Q1 25 | 39.0% | 16.5% | ||
| Q4 24 | 38.7% | 34.3% | ||
| Q3 24 | 38.5% | 46.7% | ||
| Q2 24 | 40.8% | 44.4% |
| Q1 26 | 3.3% | — | ||
| Q4 25 | 6.1% | -117.9% | ||
| Q3 25 | 6.1% | -98.6% | ||
| Q2 25 | 11.8% | -139.8% | ||
| Q1 25 | 5.3% | -104.9% | ||
| Q4 24 | 5.0% | -66.7% | ||
| Q3 24 | 6.1% | -239.9% | ||
| Q2 24 | 11.5% | -19.4% |
| Q1 26 | 1.9% | — | ||
| Q4 25 | 3.9% | -71.6% | ||
| Q3 25 | 3.9% | -61.4% | ||
| Q2 25 | 8.8% | -83.5% | ||
| Q1 25 | 3.6% | -63.9% | ||
| Q4 24 | 3.7% | -45.8% | ||
| Q3 24 | 4.6% | -140.6% | ||
| Q2 24 | 8.0% | -14.1% |
| Q1 26 | $0.24 | — | ||
| Q4 25 | $0.46 | $-0.24 | ||
| Q3 25 | $0.46 | $-0.18 | ||
| Q2 25 | $1.16 | $-0.27 | ||
| Q1 25 | $0.41 | $-0.21 | ||
| Q4 24 | $0.43 | $-0.21 | ||
| Q3 24 | $0.54 | $-0.68 | ||
| Q2 24 | $1.09 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.2M | $216.9M |
| Total DebtLower is stronger | $33.0M | $291.8M |
| Stockholders' EquityBook value | $116.7M | $212.4M |
| Total Assets | $195.2M | $770.6M |
| Debt / EquityLower = less leverage | 0.28× | 1.37× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $4.2M | — | ||
| Q4 25 | $3.6M | $216.9M | ||
| Q3 25 | $5.1M | $243.6M | ||
| Q2 25 | $3.6M | $269.9M | ||
| Q1 25 | $3.4M | $285.1M | ||
| Q4 24 | $6.4M | $322.4M | ||
| Q3 24 | $5.7M | $578.2M | ||
| Q2 24 | $3.8M | $573.2M |
| Q1 26 | $33.0M | — | ||
| Q4 25 | — | $291.8M | ||
| Q3 25 | — | $292.8M | ||
| Q2 25 | — | $293.9M | ||
| Q1 25 | — | $294.9M | ||
| Q4 24 | — | $295.9M | ||
| Q3 24 | — | $521.7M | ||
| Q2 24 | — | $522.5M |
| Q1 26 | $116.7M | — | ||
| Q4 25 | $117.6M | $212.4M | ||
| Q3 25 | $115.8M | $245.4M | ||
| Q2 25 | $113.7M | $265.9M | ||
| Q1 25 | $108.3M | $300.6M | ||
| Q4 24 | $107.0M | $325.3M | ||
| Q3 24 | $106.3M | $344.9M | ||
| Q2 24 | $104.0M | $434.7M |
| Q1 26 | $195.2M | — | ||
| Q4 25 | $171.0M | $770.6M | ||
| Q3 25 | $173.0M | $849.2M | ||
| Q2 25 | $170.9M | $897.0M | ||
| Q1 25 | $163.0M | $959.8M | ||
| Q4 24 | $162.2M | $1.0B | ||
| Q3 24 | $165.5M | $1.3B | ||
| Q2 24 | $173.5M | $1.4B |
| Q1 26 | 0.28× | — | ||
| Q4 25 | — | 1.37× | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | 1.11× | ||
| Q1 25 | — | 0.98× | ||
| Q4 24 | — | 0.91× | ||
| Q3 24 | — | 1.51× | ||
| Q2 24 | — | 1.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-22.8M |
| Free Cash FlowOCF − Capex | — | $-24.9M |
| FCF MarginFCF / Revenue | — | -49.9% |
| Capex IntensityCapex / Revenue | — | 4.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-70.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $8.2M | $-22.8M | ||
| Q3 25 | $7.1M | $-15.2M | ||
| Q2 25 | $6.3M | $-10.3M | ||
| Q1 25 | $-3.3M | $-9.4M | ||
| Q4 24 | $6.4M | $-14.6M | ||
| Q3 24 | $8.9M | $13.1M | ||
| Q2 24 | $6.9M | $17.4M |
| Q1 26 | — | — | ||
| Q4 25 | $7.3M | $-24.9M | ||
| Q3 25 | $301.0K | $-18.1M | ||
| Q2 25 | $4.7M | $-13.1M | ||
| Q1 25 | $-4.7M | $-14.6M | ||
| Q4 24 | $4.7M | $-20.5M | ||
| Q3 24 | $7.5M | $4.5M | ||
| Q2 24 | $4.4M | $7.9M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | -49.9% | ||
| Q3 25 | 0.6% | -43.4% | ||
| Q2 25 | 8.7% | -27.7% | ||
| Q1 25 | -10.2% | -31.2% | ||
| Q4 24 | 10.2% | -36.2% | ||
| Q3 24 | 15.6% | 6.6% | ||
| Q2 24 | 8.0% | 11.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 4.2% | ||
| Q3 25 | 13.8% | 7.0% | ||
| Q2 25 | 3.0% | 6.1% | ||
| Q1 25 | 2.9% | 11.2% | ||
| Q4 24 | 3.7% | 10.3% | ||
| Q3 24 | 2.8% | 12.4% | ||
| Q2 24 | 4.5% | 13.8% |
| Q1 26 | — | — | ||
| Q4 25 | 4.34× | — | ||
| Q3 25 | 3.72× | — | ||
| Q2 25 | 1.33× | — | ||
| Q1 25 | -2.02× | — | ||
| Q4 24 | 3.73× | — | ||
| Q3 24 | 3.99× | — | ||
| Q2 24 | 1.55× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACU
Segment breakdown not available.
MRVI
| Cygnus Segment | $27.2M | 54% |
| Other | $18.4M | 37% |
| Shipping And Handling | $4.3M | 9% |
